Nomura Asset Management
KRTX

Nomura Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nomura Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,883
Closed -$3.44M – 1605
2023
Q4 		$3.44M Hold
10,883
– – 0.01% 619
2023
Q3 		$1.84M Buy
10,883
+2,383
+28% +$448K 0.01% 719
2023
Q2 		$1.84M Hold
8,500
– – 0.01% 718
2023
Q1 		$1.54M Hold
8,500
– – 0.01% 748
2022
Q4 		$1.67M Buy
8,500
+2,689
+46% +$577K 0.01% 732
2022
Q3 		$1.31M Buy
+5,811
New +$1.18M 0.01% 750

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nomura Asset Management's KRTX Position: Q1 2024 in Review

Nomura Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 10,883 shares — an estimated $3.44M sold.

Nomura Asset Management first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $3.44M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Nomura Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nomura Asset Management sold 10,883 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.44M.
  • Nomura Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Nomura Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $3.44M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Nomura Asset Management's 13F filing for Q1 2024, filed 13 May 2024.